z-logo
open-access-imgOpen Access
A sharp decrease of Th17, CXCR3+-Th17, and Th17.1 in peripheral blood is associated with an early anti-IL-17-mediated clinical remission in psoriasis
Author(s) -
Sotirios G. Tsiogkas,
Αthanasios Mavropoulos,
Efthimios Dardiotis,
Efterpi Zafiriou,
Dimitrios P. Bogdanos
Publication year - 2022
Publication title -
clinical and experimental immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.329
H-Index - 135
eISSN - 1365-2249
pISSN - 0009-9104
DOI - 10.1093/cei/uxac069
Subject(s) - psoriasis , immunology , cxcr3 , interleukin 17 , peripheral blood , medicine , peripheral , inflammation , chemokine , chemokine receptor

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom